Status:
UNKNOWN
Efficacy of Uterine Lidocaine Flushing in HyFoSy
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
To Evaluate the Efficacy of Flushing the Uterine Cavity With Lidocaine Before Hysterosalpingo-Foam Sonography to Reduce Procedure-related Pain
Eligibility:
FEMALE
Phase:
NA
Brief Summary
To evaluate the efficacy of flushing the uterine cavity with lidocaine before Hysterosalpingo-Foam Sonography (HyFoSy) to reduce procedure-related pain.
Detailed Description
This randomized, double-blind, placebo-controlled trial was approved by the institutional ethics committee (# 0189-19; approval 22-09-2019) and written informed consent was obtained from all participa...
Eligibility Criteria
Inclusion
- \*all women who were referred for tubal patency evaluation as part of their fertility workup.
Exclusion
- known allergy to lidocaine.
- unprotected intercourse.
- profuse vaginal bleeding and genital tract inflammation or infections (e.g. pelvic inflammatory disease (PID).
- suspected sexually transmitted diseases (purulent vaginal discharge upon speculum insertion), salpingitis or tubo-ovarian abscess).
- psychological or neurological lesions affecting sensation, prior cervical surgery, cervical stenosis.
Key Trial Info
Start Date :
June 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04433611
Start Date
June 17 2020
End Date
December 30 2020
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yaakov Melcer
Yavné, Select A State Or Province, Israel, 8103908